Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
43.45
-1.60 (-3.55%)
At close: Dec 5, 2025

STO:IBT.B Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Other Revenue
-000.080.01--
Upgrade
-000.080.01--
Upgrade
Revenue Growth (YoY)
--94.80%541.67%---
Upgrade
Gross Profit
-000.080.01--
Upgrade
Selling, General & Admin
19.820.3514.581.021.121.14
Upgrade
Research & Development
66.1125120.1264.843.5671.09
Upgrade
Operating Expenses
85.9145.35134.6965.8244.6772.23
Upgrade
Operating Income
-85.9-145.34-134.62-65.81-44.67-72.23
Upgrade
Interest Expense
----0.29-0.41-0.3
Upgrade
Interest & Investment Income
6.178.4411.550.65-0.21
Upgrade
Other Non Operating Income (Expenses)
0---0.090.31
Upgrade
Pretax Income
-79.73-136.91-123.07-65.45-44.99-72.01
Upgrade
Net Income
-79.73-136.91-123.07-65.45-44.99-72.01
Upgrade
Net Income to Common
-79.73-136.91-123.07-65.45-44.99-72.01
Upgrade
Shares Outstanding (Basic)
131312111111
Upgrade
Shares Outstanding (Diluted)
131312111111
Upgrade
Shares Change (YoY)
-0.10%8.95%10.14%---
Upgrade
EPS (Basic)
-5.92-10.16-9.95-5.83-4.01-6.41
Upgrade
EPS (Diluted)
-5.92-10.16-9.95-5.83-4.01-6.41
Upgrade
Free Cash Flow
-60.61-113.13-101.22-85.8-55.62-58.39
Upgrade
Free Cash Flow Per Share
-4.50-8.40-8.19-7.64-4.96-5.20
Upgrade
Gross Margin
-100.00%100.00%100.00%--
Upgrade
Operating Margin
--3633575.00%-174827.27%-548400.00%--
Upgrade
Profit Margin
--3422625.00%-159828.57%-545425.00%--
Upgrade
Free Cash Flow Margin
--2828325.00%-131453.25%-714958.33%--
Upgrade
EBIT
-85.9-145.34-134.62-65.81-44.67-72.23
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.